Verastem director granted 36,000 RSUs

Kapur Anil reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Kapur Anil reported acquisition or exercise transactions in this Form 4 filing.

Verastem, Inc. director Anil Kapur received a grant of 36,000 restricted stock units (RSUs). The award was made at no cash cost per share and increased his directly held common stock-related position to 52,666 shares as reported after the transaction.

The RSUs were granted under Verastem’s Amended and Restated 2021 Equity Incentive Plan. Each RSU represents the right to receive one share of common stock, vesting in twelve substantially equal monthly installments from late June 2026 through April 2027, with the final installment vesting by May 31, 2027, if he continues serving as a director.

Insider Trade Summary

Grant/Award: 36,000 shares

Grant/Award 1 txn

Insider Kapur Anil

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	36,000	$0.00	$0.00

Holdings After Transaction: Common Stock — 52,666 shares (Direct)

Footnotes (1)

1. F1. RSUs granted to the Reporting Person under the Issuer's Amended and Restated 2021 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Common Stock. The RSUs vest in twelve substantially equal installments (rounded down to the nearest whole share on each vesting date except with respect to the final vesting date on which the remaining unvested portion shall vest). The first eleven installments shall vest beginning on the last day of each month over a period from June, 2026 to April, 2027 and the last installment shall vest on the earlier of (i) the day before the 2027 Annual Meeting of Stockholders is held or (ii) May 31, 2027, provided that the Reporting Person continues to serve as a director of the Issuer on each such vesting date.

Key Figures

RSUs granted: 36,000 units Grant price: $0.00 per share Shares after transaction: 52,666 shares +2 more

5 metrics

RSUs granted 36,000 units Grant of RSUs to director on May 21, 2026

Grant price $0.00 per share Compensation award, not open-market purchase

Shares after transaction 52,666 shares Direct holdings following RSU grant

Vesting installments 12 installments Monthly from June 2026–April 2027 plus final 2027 installment

Final vesting date By May 31, 2027 Earlier of day before 2027 annual meeting or May 31, 2027

Key Terms

RSUs, Amended and Restated 2021 Equity Incentive Plan, contingent right to receive one share of Common Stock, Annual Meeting of Stockholders

4 terms

RSUs financial

"RSUs granted to the Reporting Person under the Issuer's Amended and Restated 2021 Equity Incentive Plan."

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

Amended and Restated 2021 Equity Incentive Plan financial

"RSUs granted to the Reporting Person under the Issuer's Amended and Restated 2021 Equity Incentive Plan."

contingent right to receive one share of Common Stock financial

"Each RSU represents the contingent right to receive one share of Common Stock."

Annual Meeting of Stockholders financial

"the day before the 2027 Annual Meeting of Stockholders is held or (ii) May 31, 2027"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Verastem (VSTM) director Anil Kapur report on this Form 4?

Anil Kapur reported receiving 36,000 RSUs of Verastem common stock. The grant is a compensation award under the company’s Amended and Restated 2021 Equity Incentive Plan and did not involve an open-market stock purchase or sale.

How many Verastem (VSTM) shares does Anil Kapur hold after this RSU grant?

After the reported grant, Anil Kapur’s position totals 52,666 shares. This figure reflects his direct ownership of Verastem common stock-related holdings as disclosed in the Form 4 following the 36,000 RSU award.

What are the vesting terms of Anil Kapur’s 36,000 Verastem (VSTM) RSUs?

The 36,000 RSUs vest in twelve substantially equal installments. Eleven installments vest on the last day of each month from June 2026 through April 2027, with the final installment vesting by May 31, 2027, contingent on continued board service.

Does each RSU in Anil Kapur’s Verastem (VSTM) award equal one share?

Yes, each RSU represents the right to receive one Verastem common share. Delivery occurs as units vest according to the schedule, assuming Kapur continues to serve as a director through each relevant vesting date.

Was Anil Kapur’s Verastem (VSTM) RSU grant an open-market stock purchase?

No, the Form 4 shows a grant/award acquisition, not a market trade. The transaction code is “A,” indicating a grant or award of 36,000 RSUs at a price of $0.00 per share as part of equity compensation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/26/2026 - 06:18 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kapur Anil

(Last) (First) (Middle)

C/O VERASTEM, INC.,

117 KENDRICK ST., SUITE 500

(Street)

NEEDHAM MASSACHUSETTS 02494

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Verastem, Inc. [ VSTM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/21/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/21/2026		A		36,000(1)	A	$0.00	52,666	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. RSUs granted to the Reporting Person under the Issuer's Amended and Restated 2021 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Common Stock. The RSUs vest in twelve substantially equal installments (rounded down to the nearest whole share on each vesting date except with respect to the final vesting date on which the remaining unvested portion shall vest). The first eleven installments shall vest beginning on the last day of each month over a period from June, 2026 to April, 2027 and the last installment shall vest on the earlier of (i) the day before the 2027 Annual Meeting of Stockholders is held or (ii) May 31, 2027, provided that the Reporting Person continues to serve as a director of the Issuer on each such vesting date.

	/s/ Daniel Calkins, Attorney in Fact	05/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)